Luo MJ - Search Results

1

Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma.

Shao WQ, Zhu WW, Luo MJ, Fan MH, Li Q, Wang SH, Lin ZF, Zhao J, Zheng Y, Dong QZ, Lu L, Jia HL, Zhang JB, Lu M, Chen JH, Qin LX. Shao WQ, et al. Among authors: luo mj. Cell Rep. 2022 Apr 19;39(3):110712. doi: 10.1016/j.celrep.2022.110712. Cell Rep. 2022. PMID: 35443161 Free article.

2

Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR.

Shao W, Zhu W, Lin J, Luo M, Lin Z, Lu L, Jia H, Qin L, Lu M, Chen J. Shao W, et al. Neoplasia. 2020 Jan;22(1):1-9. doi: 10.1016/j.neo.2019.08.002. Epub 2019 Nov 18. Neoplasia. 2020. PMID: 31751859 Free PMC article.

3

Proscillaridin A inhibits hepatocellular carcinoma progression through inducing mitochondrial damage and autophagy.

Luo M, Liu Y, Liu N, Shao W, Ming L, Liu J, Xie Y. Luo M, et al. Acta Biochim Biophys Sin (Shanghai). 2021 Jan 12;53(1):19-28. doi: 10.1093/abbs/gmaa139. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 33201987 Free article.

4

AMPK induces degradation of the transcriptional repressor PROX1 impairing branched amino acid metabolism and tumourigenesis.

Wang Y, Luo M, Wang F, Tong Y, Li L, Shu Y, Qiao K, Zhang L, Yan G, Liu J, Ji H, Xie Y, Zhang Y, Gao WQ, Liu Y. Wang Y, et al. Nat Commun. 2022 Nov 24;13(1):7215. doi: 10.1038/s41467-022-34747-y. Nat Commun. 2022. PMID: 36433955 Free PMC article.

5

Transfected DNA is targeted by STING-mediated restriction.

Gu C, Ming L, Tao S, Luo M, Guo H, Xie Y, Liu J, Shen Z. Gu C, et al. Biochem Biophys Res Commun. 2021 Apr 16;549:207-213. doi: 10.1016/j.bbrc.2021.02.109. Epub 2021 Mar 5. Biochem Biophys Res Commun. 2021. PMID: 33684697

6

IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models.

Shen Z, Liu J, Wu J, Zhu Y, Li G, Wang J, Luo M, Deng Q, Zhang J, Xie Y. Shen Z, et al. Theranostics. 2019 May 31;9(13):3798-3811. doi: 10.7150/thno.35331. eCollection 2019. Theranostics. 2019. PMID: 31281514 Free PMC article.

7

Establishment of an in vitro reporter system for screening HBx-targeting molecules.

Gu C, Tao S, Hu K, Ming L, Luo M, Guo H, Su Y, Liu J, Xie Y. Gu C, et al. Acta Biochim Biophys Sin (Shanghai). 2019 Apr 1;51(4):431-440. doi: 10.1093/abbs/gmz016. Acta Biochim Biophys Sin (Shanghai). 2019. PMID: 30811522 Free article.

8

Nuclear factor Y regulates ancient budgerigar hepadnavirus core promoter activity.

Shen Z, Liu Y, Luo M, Wang W, Liu J, Liu W, Pan S, Xie Y. Shen Z, et al. Biochem Biophys Res Commun. 2016 Sep 16;478(2):825-30. doi: 10.1016/j.bbrc.2016.08.032. Epub 2016 Aug 5. Biochem Biophys Res Commun. 2016. PMID: 27501758

9

Unimpaired immunogenicity of yeast-expressed hepatitis B surface antigen stored at elevated temperatures.

Shen Z, Rao Y, Tao S, Luo M, Ming L, Liu J, Pan S, Xie Y. Shen Z, et al. Acta Biochim Biophys Sin (Shanghai). 2016 Dec;48(12):1094-1100. doi: 10.1093/abbs/gmw103. Epub 2016 Nov 8. Acta Biochim Biophys Sin (Shanghai). 2016. PMID: 27827798

10

Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial.

Liu SL, Li XY, Yang JH, Wen DX, Guo SS, Liu LT, Li YF, Luo MJ, Xie SY, Liang YJ, Sun XS, Yang ZC, Lv XF, Luo DH, Li JB, Liu Q, Wang P, Guo L, Mo HY, Sun R, Yang Q, Lan KQ, Jia GD, Li R, Zhao C, Xu RH, Chen QY, Tang LQ, Mai HQ. Liu SL, et al. Among authors: luo mj. Lancet Oncol. 2024 Dec;25(12):1563-1575. doi: 10.1016/S1470-2045(24)00504-7. Epub 2024 Nov 7. Lancet Oncol. 2024. PMID: 39522541 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters